Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ligand Pharmaceuticals Incorporated has announcedthe signing of a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion Pharmaceuticals, Inc., a venture-funded biotechnology company focused on ...
read more
Frontage Laboratories has established a joint venture with Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to provide enhanced access to high quality and economical API & intermediate development and manufacturing (CDMO) services to new US clients focused ...
read more
Hemispherx Biopharma has reached an agreement with Avrio Biopharmaceuticals, Irvine California, to serve as an additional contract manufacturer of Hemispherx’s experimental drug, Ampligen®, also known by its generic name rintatolimod.
read more
Eli Lilly and Company has announced that John C. Lechleiter, Ph.D., chairman, president and chief executive officer, will retire as president and CEO and from the company effective December 31, 2016.
read more
Bioanalytical Systems, Inc. (BASi) a provider of instrumentation for electroanalytical measurements for over 40 years, has partnered with PalmSens BV to offer handheld electrochemical analyzers, expanding its line of electrochemistry instrumentation.
read more
Selexis SA, a life sciences company and a provider of mammalian (suspension-adapted CHO-K1) cell line generation, and ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumor ...
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has reported its financial results for the second quarter ended June 30, 2016.
read more
Pharmaceutical Product Development, LLC (PPD) today announced the company has earned recognition for excellence in multimedia and digital communications for productions promoting the role of clinical research in developing life-changing medicines. ...
read more
PCI Pharma Services has announced a footprint expansion program at its site in Tredegar, South Wales. This latest expansion demonstrates continued investment in PCI Pharma Services’ Tredegar facility.
read more
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has expanded its San Diego facility to create CrownBio’s U.S. Center of Excellence for ...
read more
ProTrials Research, Inc., has announced the awarding and initiation of an agreement with Calithera Biosciences Inc., a clinical stage biotechnology company focused on the discovery and development of novel small molecule drugs directed against tumor ...
read more
Lannett Company has announced two promotions. Kristie Stephens has been appointed vice president of regulatory affairs and chief compliance officer, and John Kozlowski has been appointed vice president financial operations and corporate controller.
read more
QuVa Pharma, Inc., a recently formed national platform for sterile compounding pharmacy services, has signed an agreement to acquire an FDA approved biotech pharmaceutical facility in New Jersey.
read more
Medidata has announced that its cloud technology has been selected by Biogen to support future clinical trials. Biogen will increase its adoption of Medidata Rave®— a solution for capturing, managing and reporting patient data—and Medidata TSDV, a ...
read more
Viracor-IBT Laboratories Inc., a wholly-owned subsidiary of Eurofins Scientific, has announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Zika Virus Real-time RT-PCR assay.
read more